Showing results (1111-1120 of 7,010) with videos related to
Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|April 17, 2007
Gefitinib as palliative therapy for lung adenocarcinoma metastatic to the brainChi Wu, Yun Long Li, Zhao Meng Wang, et al.Lung Cancer (Amsterdam, Netherlands)|May 22, 2007
Low prevalence of SV40 in Swiss mesothelioma patients after elimination of false-positive PCR resultsAnnemarie Ziegler, Christian A Seemayer, Marc Hinterberger, et al.Lung Cancer (Amsterdam, Netherlands)|June 13, 2006
Validity of the Assessment of Quality of Life (AQoL) utility instrument in patients with operable and inoperable lung cancerRenee L Manser, Gavin Wright, Graham Byrnes, et al.Lung Cancer (Amsterdam, Netherlands)|June 8, 2006
Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC)Guilherme Jorge Costa, Ana Luisa Godoy Fernandes, José Rodrigues Pereira, et al.Lung Cancer (Amsterdam, Netherlands)|September 29, 2005
A willingness-to-pay study of oral epidermal growth factor tyrosine kinase inhibitors in advanced non-small cell lung cancerNatasha B Leighl, W Stephen Tsao, Dianne L Zawisza, et al.Lung Cancer (Amsterdam, Netherlands)|April 20, 2006
Results of a Phase II study of weekly docetaxel and carboplatin in Stage IIIB (with effusion) or Stage IV non-small cell lung cancer patients age<or=65 and performance status 2Charles H Weissman, John Sandbach, Reginald Brooker, et al.Lung Cancer (Amsterdam, Netherlands)|November 7, 2006
Once-weekly epoetin beta (30,000 IU) in anemic patients with lung cancer receiving chemotherapyRobert Pirker, Martina Lehnert, Wilma MinarLung Cancer (Amsterdam, Netherlands)|October 19, 2006
Endobronchial intratumoral chemotherapy (EITC) followed by surgery in early non-small cell lung cancer with polypoid growth causing erroneous impression of advanced diseaseSeyhan I Celikoglu, Firuz Celikoglu, Eugene P GoldbergLung Cancer (Amsterdam, Netherlands)|October 19, 2006
Non-responsiveness to gefitinib in a patient with lung adenocarcinoma having rare EGFR mutations S768I and V769LHajime Asahina, Koichi Yamazaki, Ichiro Kinoshita, et al.Lung Cancer (Amsterdam, Netherlands)|October 24, 2006
Integrating new targeted agents into the treatment of non-small-cell lung cancerNick ThatcherPageof 701